Free Republic
Browse · Search
News/Activism
Topics · Post Article

To: DUMBGRUNT
More than enough supposition to go around.

And who assumes the risk for the use of convalescent plasma treatment?

Who assumes the risk for the off label use of Chloroquine?

This is nothing new.

Convalescent plasma: new evidence for an old therapeutic tool?

I want to be tested to know whether I have immunity. You don't care to know?

8 posted on 04/02/2020 6:09:35 PM PDT by Shethink13 (there are 0 electoral votes in the state of denial)
[ Post Reply | Private Reply | To 4 | View Replies ]


To: Shethink13
This is nothing new.

Convalescent plasma,
True.

And what if the test allows live viruses to be transmitted? Only takes a few.

Chloroquine?
IIRC is one of the two antimalarial drugs I took for two and a half years in RVN.
https://www.military.com/daily-news/2020/03/23/drug-touted-covid-19-treatment-has-troubling-side-effects-experts-say.html

And yes, I'm perfectly normal, and have the papers to prove it! (an old joke)

Yes, I want to be tested.
Sooner or later I'd like to see my grandchildren again.
A granddaughter has some medical issues and her physician recommends avoiding everyone.

11 posted on 04/02/2020 6:31:39 PM PDT by DUMBGRUNT
[ Post Reply | Private Reply | To 8 | View Replies ]

To: Shethink13

Thank you, the abstract was interesting, will probably pass on the 796K PDF. Still might give a quick look.

This reinforces what I have previously read; there are no vaccines or CBP therapies for earlier SARS, flu, COVID... From years past.

Experiments and small studies, nothing more;
“immunotherapy using monoclonal antibodies could be more effective;”
Not exactly a dead end but the new stuff looked better.

From your link:
In the following decades, possible therapeutic efficacy was claimed for the management of measles, Argentine haemorrhagic fever, influenza, chickenpox, infections by cytomegalovirus, parvovirus B19 and, more recently, Middle East respiratory syndrome coronavirus (MERS-CoV), H1N1 and H5N1 avian flu, and severe acute respiratory infections (SARI) viruses19–29. Furthermore, animal models of influenza pneumonia have shown the benefit of CS (protection against H1 and H3 challenge), equine hyperimmune F(ab’)2 globulin (protection against H5N1 challenge), and monoclonal antibodies (against H1, H3, and H5N1 challenge)30–32.


12 posted on 04/02/2020 7:29:47 PM PDT by DUMBGRUNT
[ Post Reply | Private Reply | To 8 | View Replies ]

Free Republic
Browse · Search
News/Activism
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson